The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers.
Global analysis shows widespread eligibility for GLP-1 weight management drugs
- Post author:admin
- Post published:January 8, 2026
- Post category:uncategorized